125 related articles for article (PubMed ID: 12619540)
21. Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
Rudžianskas V; Inčiūra A; Vaitkus S; Padervinskis E; Rudžianskienė M; Kupčinskaitė-Noreikienė R; Saltonaitė L; Noreika A; Statnickaitė A; Juozaitytė E
Medicina (Kaunas); 2014; 50(2):92-9. PubMed ID: 25172603
[TBL] [Abstract][Full Text] [Related]
22. Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.
Margalit DN; Schoenfeld JD; Tishler RB
Hematol Oncol Clin North Am; 2015 Dec; 29(6):1093-106. PubMed ID: 26568550
[TBL] [Abstract][Full Text] [Related]
23. Summary of major radiation fractionation and chemotherapy trials for organ preservation therapy in locally advanced head and neck squamous cell carcinoma.
Parsons JT; Greene BD
Pract Radiat Oncol; 2015; 5(5):343-349. PubMed ID: 25920699
[TBL] [Abstract][Full Text] [Related]
24. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
[TBL] [Abstract][Full Text] [Related]
25. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
[TBL] [Abstract][Full Text] [Related]
26. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
[TBL] [Abstract][Full Text] [Related]
27. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
Stuschke M; Thames HD
Radiother Oncol; 1999 May; 51(2):113-21. PubMed ID: 10435801
[TBL] [Abstract][Full Text] [Related]
28. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
29. Fetal dose during radiotherapy: clinical implementation and review of the literature.
Nuyttens JJ; Prado KL; Jenrette JM; Williams TE
Cancer Radiother; 2002 Dec; 6(6):352-7. PubMed ID: 12504772
[TBL] [Abstract][Full Text] [Related]
30. Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.
Puc MM; Chrzanowski FA; Tran HS; Liu L; Glicksman AS; Landman C; Slotman GJ
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):337-42. PubMed ID: 10722006
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
32. Head and neck cancer. Introduction.
Brizel DM
Semin Radiat Oncol; 2009 Jan; 19(1):1-2. PubMed ID: 19028338
[No Abstract] [Full Text] [Related]
33. Head and neck cancer: preoperative radiation.
Arena S
Pa Med; 1970 Dec; 73(12):35-6. PubMed ID: 5480498
[No Abstract] [Full Text] [Related]
34. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer.
Dobrowsky W; Naudé J; Widder J; Dobrowsky E; Millesi W; Pavelka R; Grasl C; Reichel M
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):803-6. PubMed ID: 9845100
[TBL] [Abstract][Full Text] [Related]
35. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
[TBL] [Abstract][Full Text] [Related]
36. The treatment of patients with stage IV squamous cell carcinoma of the head and neck: a primary radiation therapy experience in 184 cases.
Ucmakli A
Otolaryngol Clin North Am; 1980; 13(3):529-32. PubMed ID: 7443241
[No Abstract] [Full Text] [Related]
37. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.
Servagi-Vernat S; Differding S; Sterpin E; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Acta Oncol; 2015 Jul; 54(7):1008-16. PubMed ID: 25562382
[TBL] [Abstract][Full Text] [Related]
38. Overcoming radioresistance in head and neck squamous cell carcinoma.
Yamamoto VN; Thylur DS; Bauschard M; Schmale I; Sinha UK
Oral Oncol; 2016 Dec; 63():44-51. PubMed ID: 27938999
[TBL] [Abstract][Full Text] [Related]
39. Five versus ten fractions per week radiotherapy in locally advanced head and neck cancer.
Tallari RV; Singh OP; Yogi V; Yadav S
J Cancer Res Ther; 2017; 13(2):224-229. PubMed ID: 28643738
[TBL] [Abstract][Full Text] [Related]
40. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.
Rosenthal DI; Fuller CD; Peters LJ; Thames HD
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):715-7. PubMed ID: 26104925
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
